Quad Cities Investment Group LLC Sells 225 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Quad Cities Investment Group LLC trimmed its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,525 shares of the biotechnology company’s stock after selling 225 shares during the quarter. Quad Cities Investment Group LLC’s holdings in Axon Enterprise were worth $906,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Quent Capital LLC increased its position in Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after acquiring an additional 75 shares in the last quarter. Prestige Wealth Management Group LLC grew its stake in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares during the last quarter. Brooklyn Investment Group acquired a new stake in shares of Axon Enterprise in the third quarter valued at approximately $41,000. Planning Capital Management Corp raised its position in Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares during the last quarter. Finally, Friedenthal Financial acquired a new position in Axon Enterprise during the 3rd quarter worth $51,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Down 0.2 %

Shares of Axon Enterprise stock opened at $568.68 on Tuesday. Axon Enterprise, Inc. has a 1 year low of $246.99 and a 1 year high of $698.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market capitalization of $43.36 billion, a P/E ratio of 146.95, a price-to-earnings-growth ratio of 14.19 and a beta of 1.04. The business has a 50-day moving average of $610.03 and a two-hundred day moving average of $452.93.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on AXON shares. The Goldman Sachs Group lifted their target price on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Northland Securities lifted their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. TD Cowen assumed coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Finally, Needham & Company LLC increased their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $504.92.

Insider Activity

In other news, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the sale, the director now directly owns 24,259 shares in the company, valued at $15,518,239.71. The trade was a 3.96 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock worth $30,721,337 over the last quarter. 6.10% of the stock is currently owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.